Usnoflast Neuromuscular Investigation for Treatment Efficacy in Amyotrophic Lateral Sclerosis (NCT07023835)
A Phase 2b, Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Study to Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Usnoflast Administered to Adult Subjects With ALS
🩺 Plain-English Summary (8th-Grade Level)
Usnoflast Neuromuscular Investigation for Treatment Efficacy in Amyotrophic Lateral Sclerosis
Who can join: Review the eligibility criteria below.
Location: Zydus US015 — La Jolla, California
Age range: 18 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (17 Sites)
- Zydus US015 — La Jolla, California
- Zydus US008 — Orange, California
- Zydus US013 — San Francisco, California
- Zydus US005 — New Britain, Connecticut
- Zydus US012 — Tampa, Florida
- Zydus US007 — Atlanta, Georgia
- Zydus US010 — Boston, Massachusetts
- Zydus US006 — Detroit, Michigan
- Zydus US014 — Lincoln, Nebraska
- Zydus US003 — Winston-Salem, North Carolina
- Zydus US009 — Pittsburgh, Pennsylvania
- Zydus US001 — Dallas, Texas
- Zydus US002 — Houston, Texas
- Zydus US004 — Richmond, Virginia
- Zydus US011 — Seattle, Washington
- Zydus 101 — Toronto, Ontario
- Zydus 100 — Québec, Quebec
📞 Contact the Study Coordinator
Phone: (609) 453-4751
Email: fshaikh@zydustherapeutics.com
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Amyotrophic Lateral Sclerosis (ALS)
- HEALEY ALS Platform Trial - Regimen I NUZ-001 — Boston, Massachusetts
- A Clinical Trial to Learn About the Effects of VHB937 in People With Amyotrophic Lateral Sclerosis (ALS) — La Jolla, California
- Efficacy and Safety of MSC-NTF (NurOwn) in Participants With Early Symptomatic ALS and Moderate Disease Presentation in ALS (ENDURANCE STUDY) — Phoenix, Arizona
- Resiliency Intervention for Patients With ALS and Their Care-Partners — Boston, Massachusetts
- Safety Study of XT-150 in Participants With ALS — Phoenix, Arizona
- A Phase Ⅰ/Ⅱa Study of SNUG01 in Adult Subjects With ALS — Boston, Massachusetts
Explore by condition: All Amyotrophic Lateral Sclerosis (ALS) clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.